发明名称 Pharmaceutical composition for the treatment of Lyme-borreliosis
摘要 The present invention provides for a composition to be applied in the treatment of borreliosis and a kit. The composition includes four groups of components with which group A) the components 1000-5000 mgs Cat's Claw, 1000-3000 mgs Krill Oil or Kalamarine Oil or combinations of it, 200-600 mgs Magnesium Malate, 3000-5000 mgs ester C, 100-300 mgs Alpha-Lipoic Acid, 25-75 mgs Pyridoxyl-5-Phosphate (vitamin B6), 6000-14000 IU Cholecalciferol (vitamin D3), 2000-4000 mgs He Shou Wu, 1200-2500 mgs Purple Clovers Tea, 10-50 mls parsley juice, the group B) 2000-4000 mgs Monolaurine, 400-800 mgs N-Acetylcysteine, 100-300 mgs Hyaluronic acid with BioCell collagens II, 1-5 drops Teasel Root, the group C) 10-70 drops Spilanthes Acmella and the group D) 500-1500 μg Cyancobalamin (vitamin B12). The composition and the kit is suitable to be applied in the treatment of borreliosis with which the components of the group A) are administered once daily, those of the group B) twice daily, those of the group C) three times daily and that of the group D) every 14 days.
申请公布号 US2015190412(A1) 申请公布日期 2015.07.09
申请号 US201414583126 申请日期 2014.12.25
申请人 ANDRES-FISCHER Wolfgang 发明人 ANDRES-FISCHER Wolfgang
分类号 A61K31/675;A61K36/64;A61K36/74;A61K36/28;A61K35/612;A61K47/12;A61K47/22;A61K31/385;A61K31/197;A61K31/728;A61K38/39;A61K31/714;A61K31/593;A61K36/23;A61K47/14;A61K36/70 主分类号 A61K31/675
代理机构 代理人
主权项 1. Composition containing the following components: Group A) with 1000-5000 mgs cat's claw1000-3000 mgs Krill oil or Calamarine Oil or combinations of it200-600 mgs magnesium malate3000-5000 mgs ester C100-300 mgs alpha-lipoic acid25-75 mgs pyridoxyl-5-phosphate (vitamin B6)6000-14000 IU vitamin D3 (vitamin D3)2000-4000 mgs He Shou Wu1200-2500 mgs purple clover tea10-50 mls parsley juice Group B) with 2000-4000 mgs monolaurine400-800 mgs N-Acetylcysteine100-300 mgs hyaluronic acid with. BioCell collagens II1-5 drops teasel root Group C) with 10-70 drops Spilanthes Acmella and Group D) with 500-1500 μgs Cyancobalamin (vitamin B12) to use in the treatment of borreliosis, the components of group A) being administered once daily, Group B) components twice daily, the group C) components three times daily and those of the group D) every 14 days.
地址 Germering DE